NEWS20 August 2026The approach could speed up investment decisions, but researchers say it has flaws.ByChris Stokel-Walker0Chris Stokel-WalkerChris Stokel-Walker is a freelance journalist in Newcastle, UK.View author publicationsSearch author on: PubMed Google ScholarSave articleView saved researchThe AI tool was trained on scientific publication-patent pairs.Credit: IB Photography/AlamyInvestors and technology-transfer offices expend enormous effort trying to spot commercially promising research before it reaches the point of patenting. Now, a machine-learning tool is aiming to speed up this process by scoring how ‘patent-like’ a scientific paper is — months or years before any deal, patent filing or spin-off company reveals its commercial potential. And it’s one of many proffering the same capability.The tool, called the Translation Readiness Index (TRI), performs a linguistic analysis of a paper’s title and abstract. It then measures how similar a paper’s vocabulary is to publications that have previously been paired with patents. The method was developed by researchers at the data-analytics firm League of Scholars in Sydney, Australia. The work was posted as a preprint on arXiv1 and has not yet been peer reviewed.“It’s a new way of triaging or ranking” research, says computational social scientist Paul McCarthy, co-founder of League of Scholars and a co-author on the preprint. The tool estimates the probability that a paper uses “patent-like language”, he says.Picking winnersThe researchers trained TRI on 20,610 scientific papers, including 9,431 that had been matched to patents. Titles and abstracts were fed into five classifiers, with the best-performing model having a 78% chance of ranking a patent-linked paper above an otherwise comparable paper that was not linked to a patent.Papers that were eventually cited in patents included vocabulary such as ‘prototype’, ‘device’ and ‘design’ more often than did papers that were not cited in patents. TRI analyses only titles and abstracts, so doesn’t directly assess a paper’s underlying data or results.To test whether TRI’s highest-ranked papers were correlated with other markers of commercial activity, such as whether co-authors have industry affiliations and if authors had previously patented research, the researchers looked at the 100 highest TRI-ranked papers by authors at the University of Western Australia (UWA) in Perth. The papers, published between 2019 and 2026, were more likely than a random sample to show those markers: 83 of the 100 papers had industry-affiliated co-authors, and 34 involved at least one UWA-affiliated author who had previously patented research, McCarthy says. As a result, the team is now testing TRI with several universities.Quantum meets capitalism: how to pair long-term bets on technology with commercial speedMcCarthy doesn’t recommend basing investment decisions on the tool’s results alone because it’s a probabilistic ranking. However, he says it might help to uncover “unexpected gems”.Ben Miles, co-founder of Empirical Ventures, an early-stage deep-tech investment firm based in London, says the tool could be useful as an external signal for academics and funders wanting to decide which ideas deserve further support from universities, governments or philanthropies before they are mature enough for investors.But patentable technologies aren’t always commercially viable — and so any measurement of that will always be imperfect for investors’ needs.Spin-off scoutsTRI is one of several research-scouting tools that aim to identify promising science. Some of the tools are being adopted in research institutes to help identify discoveries that could — with backing — become a viable business.One such tool, called Haystack, was built for the technology team at Cornell University in Ithaca, New York, to scan up to 13,000 papers per year — too many for Cornell’s technology-transfer team to inspect manually, says Matt Marx, who built the tool and is vice-provost for entrepreneurship, innovation and external engagement at the university.doi: https://doi.org/10.1038/d41586-026-02549-7The company League of Scholars featured in this article has previously worked with the Nature Index as a data provider. This article was produced independently of those activities.ReferencesMcCarthy, P. X., Amarasiri, R. & Gong, X. Preprint at arXiv https://doi.org/10.48550/arXiv.2606.31102 (2026).Masclans, R., Hasan, S., & Cohen, W. M. Strateg. Mgmt J. 46, 2199–2236 (2025).Article Google Scholar Download referencesWhy South Korea is the world’s biggest investor in research How I honed my biopharma dealmaking and business-development skills after my PhDQuantum meets capitalism: how to pair long-term bets on technology with commercial speed Funders, now is the time to invest big in COVID drugsStart-up investor bets on biotechSubjectsTechnologyBusinessMachine learningLatest on:TechnologyBusinessMachine learningJobs Tenure-track Faculty - Yale Center for Neuroethology and Physiological PlasticityThe Center for Neuroethology and Physiological Plasticity and the Dept. of Cellular and Molecular Physiology are seeking assistant professor faculty.New Haven, ConnecticutYale School of Medicine - The Center for Neuroethology and Physiological PlasticityFaculty - MD, PhD, MD/PhD, equivalentTexas Children's and Baylor College of Medicine - Open search for research faculty positions. All disciplines, MD, PhD, MD/PhD, equivalent.Houston, Texas (US)Texas Children's Hospital and Baylor College of MedicinePostdoctoral Fellowship — Computational Biology & GenomicsWe are a frontier artificial-intelligence laboratory, still in stealth, established for a single purpose: to build an AI capable of original discov...San Francisco, CaliforniaThe Infinity FellowshipComputational Research Scientist, Simmons Cancer CenterDrive cancer immunotherapy breakthroughs using machine learning and multi-omic data in a senior role bridging research and care.Dallas, TexasUT Southwestern Medical CenterCancer Strategic Recruitment InitiativeThe University of Alabama at Birmingham (UAB) Heersink School of Medicine (HSOM) and the O’Neal Comprehensive Cancer Center are leading a recruitmentBirmingham, Alabama (US)University of Alabama at Birmingham